Biogen stock up as sales of Leqembi beat expectations
Biogen's Leqembi, the first drug to slow the progression of Alzheimer's, launched last year
Source: qz.com
Stay updated with breaking news from Actset. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biogen's Leqembi, the first drug to slow the progression of Alzheimer's, launched last year
The Facebook parent's stock price sank as much as 12% after it reported earnings
After LSEG’s decision to sunset Redi, Anthony examines what might lie ahead for the EMS space.
Only 22% of U.S. adults have gotten an updated COVID-19 vaccine, according to the CDC
The company's stock has been on a huge rally, driven partly by AI, though it lost some ground Tuesday